Exposure to DMTs Does Not Increase Risk of Severe COVID-19 in MS Patients, Study Finds
Exposure to disease-modifying therapies does not increaseĀ multiple sclerosis (MS) patients’ risk of developing a severe form of COVID-19, according to a registry-based study. However, MS patients who are older, obese, or have severe neurological impairments have a greater risk of developing a severe form of the disease. Findings…